A Study Evaluating Long-Term Effect of Testosterone Undecanoate (TU) On Diabetic And Anthropometric Measures In Hypogonadal Men With Type-2 Diabetes Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 20 Oct 2016
At a glance
- Drugs Testosterone undecanoate (Primary)
- Indications Hypogonadism; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 20 Oct 2016 New trial record
- 16 Sep 2016 Results assessing long-term effect of testosterone-undecanoate on diabetic and anthropometric measures, presented at the 52nd Annual Meeting of the European Association for the Study of Diabetes.